Managers

AI's sharp gains in venture funding anything but artificial

DocuSign IPO seems ready for success

How to bet and win on biosciences … outside established hubs

Ex-Kleiner Perkins partners raise $298.2 mln for G2VP: Updated

Four ex-Kleiner Perkins Caufield & Byers partners have raised $298.2 million for their new firm G2VP, according to a filing with the SEC.

Angel valuations soften as deal activity spreads nationwide

Digital health funding roars ahead in Q1

Venrock healthcare survey shows pessimism on drug pricing

Skepticism remains high that the drug pricing debate will lead to action despite the FDA vowing to combat high drug prices. That was one of the findings in a survey of 300 healthcare experts conducted by the venture firm Venrock. A majority of those polled said that they believe there will still be more talk than action on prescription drug prices, with 19 percent believing that nothing will happen with prescription drug prices.

Five tips to ensure your portfolio companies are audit ready

Rally Ventures to raise $150 mln third venture fund

Rally Ventures has set out to raise a $150 million third venture capital fund, according to a filing with the SEC.

Venture activity softens in Europe during Q1